Table 4.
Ukraine (n = 939) |
Kazakhstan (n = 945) |
Azerbaijan (n = 933) |
|
---|---|---|---|
Previously diagnosed COPD | N = 10 (1.0%) | N = 13 (1.4%) | N = 4 (0.4%) |
Diagnosed by spirometry | N = 30 (3.2%) | N = 63 (6.7%) | N = 35 (3.8%) |
Firstly diagnosed by spirometry | N = 27 (2.9%) | N = 58 (6.1%) | N = 33 (3.5%) |
COPD severity by GOLD stagea: | |||
I (Mild) | 13 (1.4%) | 26 (2.8%) | 13 (1.4%) |
II (Moderate) | 17 (1.8%) | 37 (3.9%) | 22 (2.4%) |
GOLD Stage I (Mild): FEV1/FVC < 0.70 and FEV1 ≥ 80% predicted
GOLD Stage II (Moderate): FEV1/FVC < 0.70 and 50% ≤ FEV1 < 80% predicted
aThere were no respondents diagnosed with COPD III or IV GOLD stages